William Ma, CIO of GROW Investment Group, discusses his markets outlook with Juliette Saly on Bloomberg Daybreak Asia. Bloomberg Daybreak Asia.
See Original Article
Biologics to Remain Preferred Drug Class for Rare Neurological Disease Treatment, Accounting for 40% of Sales through 2028. Published: Sep 21, 2021.
See Original Article
As per the study,the global Online Accounting System and Tools market was valued at USDXX and is expected to expand to USDXX by 2027, surpassing only USDXX, and
See Original Article
… for its app, a long-awaited move that will make it easier for customers to send and receive digital currencies like Bitcoin, Bloomberg News reports.
See Original Article
Sofia Horta E Costa, Bloomberg Chief China Markets Correspondent, discusses the latest on Evergrande with Juliette Saly on Bloomberg Daybreak Asia.
See Original Article

Leave a Reply